GGrantIndex
← Leaderboards

Raymond E Meyn

University Of Texas Md Anderson Can Ctr

$4,117,563
Attributed
$4,117,563
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $539.2K · FY200515
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$4,117,563 · 4

By mechanism

R01$2,690,270 · 2
P01$1,252,370 · 1
R41$174,923 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Apoptosis

Research focus

ApoptosisGene ExpressionCell LineNeoplasm /Cancer Radiation TherapyWestern BlottingsNeoplastic CellTumorOncogenesMolecularTumor Suppressor GenesGlutathioneSignal TransductionFundingBcl2 Gene /ProteinBaseMitochondriaTissue /Cell CultureIn VivoNormal Tissue MorphologyIntracellular TransportIn VitroAntioxidantsAntineoplasticsFuture

Grant awards (19)

Extension of Radiotherapy Research$295,023
R01 · FY2015 · CA · contact PI
Extension of Radiotherapy Research$285,013
R01 · FY2014 · CA · contact PI
Extension of Radiotherapy Research$275,125
R01 · FY2013 · CA · contact PI
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS$282,496
P01 · FY2008 · CA · contact PI
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS$281,477
P01 · FY2007 · CA · contact PI
Anticancer Drug Resistance by Bcl-2 Oncogene Expression$257,716
R01 · FY2007 · CA · contact PI
Anticancer Drug Resistance by Bcl-2 Oncogene Expression$265,413
R01 · FY2006 · CA · contact PI
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS$163,275
P01 · FY2006 · CA · contact PI
Anticancer Drug Resistance by Bcl-2 Oncogene Expression$271,800
R01 · FY2005 · CA
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS$159,568
P01 · FY2005 · CA
Anticancer Drug Resistance by Bcl-2 Oncogene Expression$294,300
R01 · FY2004 · CA
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS$155,190
P01 · FY2004 · CA
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION$254,059
R01 · FY2002 · CA
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE$0
P01 · FY2002 · CA
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION$248,575
R01 · FY2001 · CA
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE$0
P01 · FY2001 · CA
ANTICANCER DRUG RESISTANCE BY BCL2 ONCOGENE EXPRESSION$243,246
R01 · FY2000 · CA
ROLE OF PROGRAMMED CELL DEATH IN RADIATION RESPONSE$210,364
P01 · FY2000 · CA
TUMOR CELL RADIOSENSITIZATION BY ADENOVIRAL-MEDIATED P16$174,923
R41 · FY2000 · CA